An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis

1. Denton, C.P.
2. Engelhart, M.
3. Tvede, N.
4. Wilson, H.
5. Khan, K.
6. Shiwen, X.
7. Carreira, P.E.
8. Diaz Gonzalez, F.
9. Black, C.M.
10. Van Den Hoogen, F.H.